U.S. Congress legislation · 119th Congress
HB9774: To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
Status: In committee, July 20, 2026
What the bill says
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
From the introduced text, July 20, 2026:
A BILL To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes. SECTION 1. Priority nonprescription drugs (a) In general The Federal Food, Drug, and Cosmetic Act is amended by inserting after section 506L ( 21 U.S.C. 356l ) the following: SECTION 506M. Priority nonprescription drugs (a) In general (1) Designation The Secretary may, at the request of the sponsor of a nonprescription drug, designate as a priority nonprescription drug under this section a drug intended for nonprescription use that is subject to an application submitted (or to be submitted) under section 505(b), if the Secretary determines that the drug meets the criteria specified in subsection (d). (2) Nonprescription defined In this section, the term nonprescription means, with respect to a drug, that such drug is not subject to section 503(b)(1). (b) Request for designation The sponsor of a drug subject to a pending application under section 505(b) for nonprescription use may request that the Secretary designate the drug as a priority nonprescription drug. (c) Designation Not later than 60 calendar days after the receipt of a request under subsection (b), the Secretary shall determine whether a drug meets the criteria for designation as a priority nonprescription drug under this section, and if so, make such designation. (d) …
Sponsors
- Robert Latta (R, HD-005) · primary sponsor
- Greg Landsman (D, HD-001)
Latest actions
- : Referred to the House Committee on Energy and Commerce.
- : Introduced in House
Subjects: Health
Common questions
- What is HB9774?
- HB9774 is a bill in Congress (119th Congress): To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
- What does HB9774 do?
- In its own words: To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
- What is the status of HB9774?
- In committee as of July 20, 2026. Latest action: Referred to the House Committee on Energy and Commerce. (July 20, 2026).
- Who sponsored HB9774?
- Robert Latta (R, HD-005), with 1 co-sponsor.
- Where is the official record for HB9774?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/9774
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.